9 Ergebnisse.

Keine Beschreibung.

Keine Beschreibung.

Keine Beschreibung.

Cannabis consumption, commerce, and control in global history, from the nineteenth century to the present day.This book gathers together authors from the new wave of cannabis histories that has emerged in recent decades. It offers case studies from Africa, Asia, the Americas, Europe, and the Middle East. It does so to trace a global history of the plant and its preparations, arguing that Western colonialism shaped and disseminated ideas in the...

Lucas Richert, Director of the American Institute for the History of Pharmacy, breaks through the assumptions and breaks down the history of the radical challenges to psychiatry and the conventional treatment of mental health in the 1970s.The upheavals of the 1960s gave way to a decade of disruptions in the 1970s, and among the rattled fixtures of American society was mainstream psychiatry. A "Radical Caucus" formed within the psychiatric prof...

Antipsychiatry, ” Esalen, psychedelics, and DSM III: Radical challenges to psychiatry and the conventional treatment of mental health in the 1970s.The upheavals of the 1960s gave way to a decade of disruptions in the 1970s, and among the rattled fixtures of American society was mainstream psychiatry. A "Radical Caucus” formed within the psychiatric profession and the "antipsychiatry” movement arose. Critics charged that the mental health estab...

Lucas Richert is the George Urdang Chair in the History of Pharmacy at the University of Wisconsin-Madison.

In the last quarter of the 20th century, politicians in Washington, as well as interest groups, regulatory policy makers, and drug industry leaders were forced to confront the hot-button issue of pharmaceutical regulation. The struggle always centered on product innovation, consumer protection, and choice in the free market. As the American economy stuttered in the late 1970s, the stakes were extremely high for the powerful drug industry and t...

In the last quarter of the 20th century, politicians in Washington, as well as interest groups, regulatory policy makers, and drug industry leaders were forced to confront the hot-button issue of pharmaceutical regulation. The struggle always centered on product innovation, consumer protection, and choice in the free market. As the American economy stuttered in the late 1970s, the stakes were extremely high for the powerful drug industry and t...